Fate Therapeutics Inc (FATE) SEC Filings — 2024

Filings

• Fate Therapeutics Announces Executive Changes and Board Election — 8-K · Nov 29, 2024
• Fate Therapeutics Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Fate Therapeutics Q3 2024 Update — 10-Q · Nov 12, 2024
• Fate Therapeutics Inc SC 13G/A Filing — SC 13G/A · Nov 8, 2024
• Fate Therapeutics Inc SC 13G/A Filing — SC 13G/A · Oct 25, 2024
• Fate Therapeutics Inc SC 13G/A Filing — SC 13G/A · Oct 21, 2024
• Fate Therapeutics Director Departs; Filings Detail Compensation — 8-K · Aug 30, 2024
• Fate Therapeutics Files 10-Q for Q2 2024 — 10-Q · Aug 13, 2024
• Fate Therapeutics Appoints New CMO and CSO — 8-K · Jul 31, 2024
• Fate Therapeutics Files 8-K for Charter Amendments — 8-K · Jun 10, 2024
• Fate Therapeutics Files 8-K on Director Changes and Officer Appointments — 8-K · Jun 7, 2024
• Fate Therapeutics Appoints New Directors, One Resigns — 8-K · May 31, 2024
• Fate Therapeutics Adopts New Equity Incentive Plan — 8-K · May 9, 2024
• Fate Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• FATE THERAPEUTICS INC Files Definitive Proxy Statement — DEF 14A · Apr 26, 2024
• Redmile Group Adjusts Fate Therapeutics Stake — SC 13D/A · Mar 25, 2024
• Fate Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Mar 21, 2024
• Fate Therapeutics Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 26, 2024
• Fate Therapeutics Inc SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Boxer Capital Discloses 10.0% Stake in Fate Therapeutics — SC 13G · Feb 12, 2024
• Capital World Investors Dumps Entire FATE Stake — SC 13G/A · Feb 9, 2024
• Point72 Discloses 4.73M Share Stake in Fate Therapeutics — SC 13G · Jan 25, 2024
• BlackRock Amends Fate Therapeutics Stake, Filing 13G/A — SC 13G/A · Jan 24, 2024
• State Street Corp. Updates Passive Stake in Fate Therapeutics — SC 13G/A · Jan 22, 2024